333 Coney St
48 articles with Siemens Healthineers
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for May 5, 2020.
Siemens Healthineers announced the availability of its molecular Fast Track Diagnostics SARS-CoV-2 Assay test kit used to aid in the diagnosis of infection by the SARS-CoV-2 virus that causes the COVID-19 disease.
FDA Clears Siemens Healthineers RAPIDPoint 500e Blood Gas Analyzer Used for Critically Ill Patients in Acute Care Settings
Siemens Healthineers announced today that its latest critical care testing solution, the RAPIDPoint® 500e Blood Gas Analyzer, has received clearance from the U.S. Food and Drug Administration.
Siemens Healthineers Wins Bid to Become Primary Supplier for Quest Diagnostics Immunoassay Testing with Atellica Solution
Quest plans to standardize its immunoassay testing across 19 core laboratories, including a new flagship lab in Clifton, New Jersey with Atellica Solution and automation
Siemens Healthineers and Hamilton Health Sciences announce formation of new Value Partnership to enhance imaging services in southwestern Ontario
Value partnership over 15-year period will see the provision of the latest imaging equipment to transform care delivery for patients across southwestern Ontario
Mobile CT scanner enables patient to remain in the ICU while connected to monitors and devices
myExam Companion intelligent user interface concept guides technologists through complex clinical tasks
Neuroradiologist in Toronto Performs World’s First Robotic-Assisted Aneurysm Coiling Using Corindus Technology
Novel procedure marks a pivotal step in implementation of robotics to address neurovascular disease
Gryphon Investors, a San Francisco-based middle-market private equity firm, announced that it has entered definitive documentation to sell its portfolio company ECG Management Consultants to Siemens Medical Solutions USA, Inc., a subsidiary of Siemens Healthineers AG.
Siemens Healthineers and HealthyWomen, the nation’s leading independent, nonprofit health information source for women, today announced results from a new national survey designed to deepen understanding on how to improve women’s experiences with screening mammograms for breast cancer detection.
Bragar Eagel & Squire, P.C. is Investigating the Board of Directors of Corindus Vascular Robotics, Inc. (NYSE: CVRS) on Behalf of Corindus Shareholders and Encourages Corindus Investors to Contact the Firm
Pursuant to the proposed transaction, announced on August 8, 2019 and valued at $1.1 billion, Corindus shareholders will receive $4.28 in cash for each share of Corindus common stock owned.
Corindus Vascular Robotics announced that it has entered into a definitive merger agreement to be acquired by Siemens Healthineers AG.
Siemens Healthineers Earns Acclaim from Frost & Sullivan for Employing AI to Reduce Variability in Imaging
The company's holistic product line generates highly precise images for improved patient outcomes
Siemens Healthineers Exhibits Solutions That Drive Outcomes That Matter to Healthcare Providers and Patients
Siemens Healthineers will showcase its unique, customizable offerings for in vitro diagnostics testing designed to improve workflow, efficiency and clinical outcomes.
Siemens Healthineers Hemoglobin A1c Test for Diagnosing and Monitoring Diabetes Now Available on the Atellica Solution
Siemens Healthineers announced the global availability of its new Atellica CH Enzymatic Hemoglobin A1c (A1c_E) Assay to assist clinicians in diagnosing and monitoring diabetes, a growing and potentially deadly disease.
10 Billion Lab Tests and Growing: Siemens Healthineers Mass. Manufacturing Expansion Largely Completed
Siemens Healthineers invested $300M in the Walpole, Mass. laboratory diagnostics manufacturing facility bringing up to 700 local, high-tech jobs to Massachusetts.
Multimillion-Dollar Investment in the Atellica Solution will Transform Pathology Testing across Australia
Siemens Healthineers and Primary Health Care team up to revolutionize healthcare outcomes in pathology.
Siemens Healthineers and Healthy.io Align Expertise to Improve Kidney Disease Compliance with Home Testing
The companies will integrate Siemens Healthineers urinalysis reagents into the Healthy.io’s smartphone-based urinalysis system.
Big News for Little Patients as Cincinnati Children’s Hospital Advances its Pediatric Testing with the Atellica Solution
Cincinnati Children’s Hospital Medical Center, one of the most distinguished pediatric hospitals in the U.S., is the first children’s hospital to adopt the Atellica® Solution.
Siemens Healthineers has announced that its Ottawa, Ontario manufacturing facility that manufactures the epoc® blood analysis system will be expanded by 5000 square feet to support new manufacturing lines and accommodate growth of the healthcare business worldwide and in Canada.